THE RELATIONSHIP BETWEEN TUMOUR DOSIMETRY AND OTHER PREDICTIVE AND PROGNOSTIC FACTORS IN PATIENTS WITH UNRESECTABLE NEUROENDOCRINE NEOPLASM (NEN) TREATED WITH PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT)

被引：0
|
作者：
Alipour, Ramin [1 ]
机构：
[1] Peter Maccallum Canc Ctr, Melbourne, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [21] The role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT).
    Abou Jokh Casas, Estephany
    Lago, Nieves Martinez
    Cabezas Agricola, Jose Manuel
    Herranz, Urbano Anido
    Baron, Francisco
    Calvo, Ovidio Fernandez
    Varela, Maria Quindos
    Ferreiro, Silvia Varela
    Maseda, Alberto Carral
    De Matias Leralta, Jose Maria
    Seoane, Zulema Nogareda
    Castineira, Antia Cousillas
    Martinez de LLano, Sofia Rodriguez
    Mato Mato, Jose Antonio
    Catalina, Pablo Fernandez
    Fonseca, Omar Rodriguez
    Garcia, Gloria Muniz
    Bernardez, Beatriz
    Cameselle Teijeiro, Jose Manuel
    Nunez, Virginia Pubul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [22] Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Metastatic Neuroendocrine Tumors: How Effective and Safe Are They?
    Liotsou, T.
    Stefanoyiannis, A. P.
    Chatziioannou, S. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S725 - S726
  • [23] Prognosis of patients with carcinoid heart disease treated by peptide receptor radionuclide therapy (PRRT)
    Prasad, V.
    Secknus, M. A.
    Hoersch, D.
    Kuntze, T.
    Zachert, C.
    Baum, R. P.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [24] Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
    Sue Ping Thang
    Mei Sim Lung
    Grace Kong
    Michael S. Hofman
    Jason Callahan
    Michael Michael
    Rodney J. Hicks
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 323 - 323
  • [25] Overall outcome of peptide receptor radionuclide therapy (PRRT) in treatment metastatic progressive neuroendocrine tumors (NETs): Survival, toxicity and prognostic factors
    Alsadik, S. R.
    Gnanasegaran, G.
    Chen, L.
    Toumpanakis, C.
    Caplin, M.
    Navalkissoor, S.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 171 - 171
  • [26] Retreatment with peptide receptor radionuclide therapy in patients with progressing neuroendocrine tumours: efficacy and prognostic factors for response
    Vaughan, Emily
    Machta, Joseph
    Walker, Martin
    Toumpanakis, Christos
    Caplin, Martyn
    Navalkissoor, Shaunak
    BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1091):
  • [27] Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Metastatic Low Grade Neuroendocrine Tumors (mNETs)
    Naraev, Boris G.
    Sharma, Nancy
    Engelman, Eric S.
    Bushnell, David L., Jr.
    O'Dorisio, Thomas M.
    Halfdanarson, Thorvardur R.
    PANCREAS, 2012, 41 (02) : 347 - 348
  • [28] Safety in Patients With Neuroendocrine Tumors Receiving Telotristat Ethyl (TE) With Peptide Receptor Radionuclide Therapy (PRRT)
    Chauhan, A.
    Binder, P.
    Tesfaye, E.
    Seth, K.
    Lapuerta, P.
    PANCREAS, 2021, 50 (03) : 447 - 448
  • [29] Quality Of Life in Patients with Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy
    Wang, Q.
    Librizzi, D.
    Bagheri, S.
    Ebrahimifard, A.
    Luster, M.
    Yousefi, B. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S246 - S247
  • [30] Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT)
    Chan, David L.
    Clarke, Stephen J.
    Engel, Alexander
    Diakos, Connie I.
    Pavlakis, Nick
    Roach, Paul J.
    Bailey, Dale L.
    Bauer, Judith
    Findlay, Merran
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2022, 76 (01) : 143 - 149
12345